dissolution-rate-limited absorption

When a drug is hard to dissolve but, once dissolved, crosses the gut wall easily, the bottleneck for absorption is the dissolving step itself. Picture a sponge that drinks water faster than you can pour: the membrane (the sponge) is thirsty, but it can only take what little has dissolved. The slow, limiting tap is dissolution — hence dissolution-rate-limited absorption.

This is the signature of BCS Class II drugs: low solubility, high permeability. Because the membrane is never the constraint, anything that speeds dissolution speeds absorption — reducing particle size (micronization or nanocrystals), choosing a more soluble salt or amorphous form, using surfactants, cyclodextrins, cosolvents, or solid dispersions. The Noyes-Whitney equation captures the levers: dissolution rate rises with surface area and solubility and falls as the diffusion boundary layer thickens.

The opposite case is permeability-rate-limited (or membrane-limited) absorption, typical of Class III drugs, where the drug dissolves freely but crosses the membrane slowly — and there formulation tricks that boost dissolution do little. Identifying which step limits a given drug is the first strategic question in oral formulation, because it tells you where effort will and won't pay off.